APA (7th ed.) Citation

Matos, L., Santos, J., Rocha, M., Coutinho, M., Prata, M., & Alves, S. (2020). The use of a modified U1 snRNA as a therapeutic strategy to correct a 5’ splice-site mutation in Mucopolysaccharidosis IIIC: In vitro steps towards an in vivo approach.

Chicago Style (17th ed.) Citation

Matos, L., J.I Santos, M. Rocha, M.F Coutinho, M.J Prata, and S. Alves. The Use of a Modified U1 SnRNA as a Therapeutic Strategy to Correct a 5’ Splice-site Mutation in Mucopolysaccharidosis IIIC: In Vitro Steps Towards an in Vivo Approach. 2020.

MLA (8th ed.) Citation

Matos, L., et al. The Use of a Modified U1 SnRNA as a Therapeutic Strategy to Correct a 5’ Splice-site Mutation in Mucopolysaccharidosis IIIC: In Vitro Steps Towards an in Vivo Approach. 2020.